GSKCONS

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Resignation of Mr Vivek Anand as Executive Director of the company w.e.f. September 27, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Cessation of Mr Kunal Kashyap as Independent Director of the company w.e.f. August 02, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Cessation of Mr Naresh Dayal as Independent Director of the company w.e.f. August 02, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Reappointment of Director of the company.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that at the Board Meeting held on August 5, 2016, Mr. Anup Dhingra has been appointed as an Executive Director of the Company, with effect from September 1, 2016, in the casual vacancy created by the resignation of Mr. Jaiboy John Phillips, who will hold office till August 31, 2016.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that at the Fifty Seventh Annual General Meeting of the Company held on August 5, 2016, at Nabha (Punjab), Mr. Kunal Kashyap, Mr. P Dwarakanath, Mr. Naresh Dayal, Mr. Mukesh H Butani, Ms. Sangeeta Talwar, Mr. Jaiboy John Phillips and Mr. Vivek Anand were elected as Directors by the shareholders through the system of proportional representation.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that Ms. Shanu Saksena, has been appointed as the Company Secretary and Compliance Officer of the Company as per Regulation 6 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 at the Board Meeting held on August 05, 2016.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that Ms. Sonali Khanna, Company Secretary and Compliance Officer of the Company has resigned and the Board of Directors at its meeting held on May 17, 2016, has accepted her resignation and accordingly Ms. Sonali Khanna ceases to be a Company Secretary and Compliance Officer of the Company with effect from the closing hours of May 17, 2016.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board noted that Horlicks Limited had withdrawn the Nomination of Mr. Jonathan Box and nominated Mr. Joaquin Beneyto Mascaro in his place, as the Director of the Company with effect from May 17, 2016, under Article 97-A of the Articles of Association of the Company. Further, Ms. Sonali Khanna, Company Secretary and Compliance Officer of the Company has resigned and the Board of Directors at its meeting held on May 17, 2016, has accepted her resignation and accordingly Ms. Sonali Khanna ceases to be a Company Secreta

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that Mr. Manoj Kumar has been appointed as the Managing Director of the Company in place of Mr. Zubair Ahmed with effect from June 1, 2015 under the provisions of Article 97 A of the Articles of Association of the Company and approved by the Board of Directors at its meeting held on May 8, 2015. Board noted the withdrawal of nomination by Horlicks Limited of Mr. Zubair Ahmed as the Director of the Company with effect from the close of business hours on May 31, 2015 and accepted his resignation. The Board had also appo

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that Mr. Ramakrishnan Subramanian, consequent to his promotion to a global role, has resigned as Director Finance and Chief Financial Officer of the Company with effect from the closing hours of May 31, 2015.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 06, 2014 on the recommendation of the Nomination & Remuneration Committee, appointed Ms. Sangeeta Talwar, as an Independent Director of the Company, in the casual vacancy created by the resignation of Ms. Ireena Vittal.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange Ms. Ireena Vittal, Independent Director of the Company has resigned w.e.f. May 1, 2013.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that Ms. Sonali Khanna has been appointed as the Company Secretary w.e.f. August 01, 2013 in place of Mr. Surinder Kumar, who had decided to step down as the Company Secretary of the Company.Further, Ms. Sonali Khanna shall also act as the Compliance Officer with effect from August 01, 2013

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that Mr Ramakrishnan Subramanian, Director- Finance & IT and CFO of the Company, a Nominee Director of the Company's Promoters, Horlicks Ltd. under Article 97 A of the Articles of Association of the Company, has resigned as Director of the Company w.e.f the close of business hours of March 30, 2009, upon withdrawal of his nomination. The Company has also informed that Mr Ramakrishnan Subramanian will however continue as Chief Financial Officer of the Company.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that: "Mr. Gautam K Chakraborty, Director - Finance & IT and CFO of the Company, a nominee Director of the Company's Promoters, Horlicks Ltd., under Article 97 A of the Articles of Association of the Company, is resigning as Director of the Company w.e.f. November 30, 2007 upon withdrawal of his nomination".

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the following persons have been elected as Directors of the Company at the Annual General Meeting held on April 27, 2007. These Directors have been appointed under a system of proportional representation and shall hold office for a period of three years with effect from April 27, 2007 up to the Annual General meeting of 2010. The Directors appointed are: (1) Mr. Praveen K. Gupta. (2) Mr. P Dwarakanath. (3) Mr. Ashok Dayal. (4) Mr. P Murari. (5) Mr. Kunal Kashyap. (6) Mr. Subodh Bhargava.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "Mr. Zubair Ahmed has been appointed as the Managing Director of the Company in Place of Mr. Nicholas J Massey w.e.f. January 1, 2007 under the provisions of Article 97-A of the Articles of Association of the Company and approved by the Board of Directors at its meeting held today (19 Dec 2006) at 1.00 p.m. at the Company's Corporate Office at DLF Plaza Tower, DLF City, Phase- 1, Gurgaon- 122002".

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "Mr. Zubair Ahmed has been appointed as Vice President & General Manager of the Company with effect from 1 December 2006".

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that Mr. P Dwarakanath will retire as Wholetime Director of the Company w.e.f. July 31, 2006 upon attaining the age of retirement. Mr. P Dwarakanath will however continue as the Non Executive Director on the Board of the Company. This has been taken note of by the Board of Directors at its meeting held on July 27, 2006. The Company has further informed that Mr. Arun Sehgal has been appointed as the Vice President - Human Resources and Administration.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board at its meeting held on January 24, 2006 have taken note of the appointment of Mr. Praveen K Gupta who has been nominated as Wholetime Director by Horlicks Limited under Article 97-A of the Articles of Association of the Company with effect from January 24, 2006 in place of Mr. David S Allen who ceased to be a Director with effect from January 24, 2006.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that Mr. Praveen Kumar Gupta has been nominated as Nominee Director of Horlicks Limited, U.K., w.e.f. January 24, 2006 to replace Mr. David S. Allen. This will be placed before the next Board meeting of the Company to give effect to the changes. Further, the Company has appointed Mr. Ramakrishnan Subramanian as Deputy Chief Financial Officer w.e.f. January 11, 2006.